Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma
Clinical trial NCT01920191 · COMPLETED
Trial details
- NCT number
- NCT01920191
- Sponsor
- University Hospital, Geneva
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.